Form 8-K - Current report:
SEC Accession No. 0000950170-21-001712
Filing Date
2021-09-08
Accepted
2021-09-08 16:30:47
Documents
12
Period of Report
2021-09-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K alec-20210908.htm   iXBRL 8-K 48261
  Complete submission text file 0000950170-21-001712.txt   168564

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20210908.xsd EX-101.SCH 2472
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20210908_pre.xml EX-101.PRE 10280
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20210908_lab.xml EX-101.LAB 14020
5 EXTRACTED XBRL INSTANCE DOCUMENT alec-20210908_htm.xml XML 4914
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 211242435
SIC: 2836 Biological Products, (No Diagnostic Substances)